GOZZINI, ANTONELLA
GOZZINI, ANTONELLA
ACETYLATION INDUCED BY BUTYRATES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA CAN LEAD TO DIFFENTIATION
2002 A. Gozzini; E. Rovida; A Pratesi; P. Dello Sbarba; P Rossi Ferrini; V. Santini
Acetylome and phosphoproteome modifications in imatinib resistant chronic myeloid leukaemia cells treated with valproic acid.
2011 Buchi F; Pastorelli R; Ferrari G; Spinelli E; Gozzini A; Sassolini F; Bosi A; Tombaccini D; Santini V
Autologous haematopoietic stem cell transplantation affects long-term progression independent of relapse activity in aggressive multiple sclerosis: a comparative matched study
2025 Mariottini, Alice; Mazzeo, Anna Chiara; Simonetti, Edoardo; Boncompagni, Riccardo; Covicchio, Jessica; Barilaro, Alessandro; Cutini, Ilaria; Di Cristinzi, Maria; Gozzini, Antonella; Mattei, Alessandra; Mealli, Fabrizia; Repice, Anna Maria; Nozzoli, Chiara; Massacesi, Luca
Autologous haematopoietic stem cell transplantation affects paramagnetic rim lesions in multiple sclerosis
2026 Mariottini, Alice; Ginestroni, Andrea; Carlesi, Edoardo; Di Pasquale, Francesca; Simonetti, Edoardo; Noferini, Linhsia; Gozzini, Antonella; Costantini, Gaia; Repice, Anna M.; Reich, Daniel S.; Fainardi, Enrico; Nozzoli, Chiara; Massacesi, Luca
Butyrates as single drug induce histone acetylation and granulocytic maturation: possible selectivity on core binding factor-acute myeloid leukemia blasts.
2003 A.GOZZINI; E.ROVIDA; P.DELLO SBARBA; S.GALIMBERTI; V. SANTINI
Complete remission with brentuximab vedotin in a case of primary cutaneous gamma-delta T-cell lymphoma relapsed after allogeneic stem cell transplantation
2021 Lastrucci, Irene; Grandi, Vieri; Gozzini, Antonella; Vannucchi, Margherita; Kovalchuk, Sofya; Santucci, Marco; Pimpinelli, Nicola
EPIGENETIC MODIFICATIONS IN A T(8;21) ACUTE MYELOID LEUKEMIA CELL LINE CAUSED BY ADMINISTRATION OF THE HDAC INHIBITOR D1
2004 V. Barbetti; E. Rovida; A. Gozzini; S. Giuntoli; V. Santini; P. Dello Sbarba
Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine
2014 VALENCIA MARTINEZ, ANA BELEN; Masala, Erico; Rossi, A.; Martino, A.; Sanna, A.; Buchi, Francesca; Canzian, F.; Cilloni, D.; Gaidano, V.; Voso, M. T.; Kosmider, O.; Fontenay, M.; Gozzini, A.; Bosi, Alberto; Santini, Valeria
Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine.
2014 Valencia A; Masala E; Rossi A; Martino A; Sanna A; Buchi F; Canzian F; Cilloni D; Gaidano V; Voso MT; Kosmider O; Fontenay M; Gozzini A; Bosi A; Santini V.
Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients.
2016 Bocchia, M; Galimberti, S; Aprile, L; Sicuranza, A; Gozzini, A; Santilli, F; Abruzzese, E; Baratè, C; Scappini, B; Fontanelli, G; Trawinska, Mm; Defina, M; Gozzetti, A; Bosi, A; Petrini, M; Puccetti, L
HDAC INHIBITORS IN COMBINATION WITH HYPOMETHYLATING AGENTS INDUCE SPECIFIC CHROMATIN MODIFICATION AND TRANSCRIPTIONAL ACTIVATION IN CBF/AML CELLS
2005 A. Gozzini; V. Barbetti; E. Rovida; S. Giuntoli; P. Dello Sbarba; V. Santini
In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features
2020 Tusa I.; Cheloni G.; Poteti M.; Silvano A.; Tubita A.; Lombardi Z.; Gozzini A.; Caporale R.; Scappini B.; Dello Sbarba P.; Rovida E.
INCUBATION OF MURINE ERYTHROLEUKEMIA CELLS IN SEVERE HYPOXIA INDUCES MASSIVE APOPTOSIS PARALLELED BY AKT AND ERK5 CLEAVAGE
2004 S. Giuntoli; E. Rovida; V. Barbetti; A. Gozzini; P. Dello Sbarba
Iron overload and iron chelation therapy in patients with myelodysplastic syndrome treated by allogeneic stem-cell transplantation: Report from the working conference on iron chelation of the Gruppo Italiano Trapianto di Midollo
2011 Alessandrino EP; Angelucci E; Cazzola M; Porta MG; Di Bartolomeo P; Gozzini A; Malcovati L; Pioltelli P; Sica S; Bosi A
Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib
2015 Castagnetti, F; Gugliotta, G; Breccia, M; Stagno, F; Iurlo, A; Albano, F; Abruzzese, E; Martino, B; Levato, L; Intermesoli, T; Pregno, P; Rossi, G; Gherlinzoni, F; Leoni, P; Cavazzini, F; Venturi, C; Soverini, S; Testoni, N; Alimena, G; Cavo, M; Martinelli, G; Pane, F; Saglio, G; Rosti, G; Baccarani, M; Bosi, A; Gozzini, A
MAPKS ARE INVOLVED IN THE SURVIVAL AND DIFFERENTIATION OF A T(8;21) ACUTE MYELOID LEUKEMIA CELL LINE AND ARE MODULATED BY THE HDAC INHIBITOR D1
2004 E. Rovida; A. Gozzini; V. Barbetti; S. Giuntoli; V. Santini; P. Dello Sbarba
Mutated ASXL1 and number of somatic mutations as possible indicators of progression to chronic myelomonocytic leukemia of myelodysplastic syndromes with single or multilineage dysplasia
2017 Valencia-Martinez, Ana; Sanna, Alessandro; Masala, Erico; Contini, Elisa; Brogi, Alice; Gozzini, Antonella; Santini, Valeria
Redistribution of H3K27me3 and acetylated histone H4 upon exposure to azacitidine and decitabine results in de-repression of the AML1/ETO target gene IL3.
2014 Buchi F; Masala E; Rossi A; Valencia A; Spinelli E; Sanna A; Gozzini A; Santini V.
Safety of Prophylactic Anakinra in Patients Treated with CD28-Based CD19 Chimeric Antigen Receptor-T Cells for R/R B-Cell Lymphoma
2026 Cutini, Ilaria; Camerini, Chiara; Coltro, Giacomo; Gozzini, Antonella; Simonetti, Edoardo; Giordano, Mirella; Mirabella, Gaia; Mazzoni, Alessio; Matani, Francesca; Caporale, Roberto; Bencini, Sara; Peruzzi, Benedetta; Nassi, Luca; Puccini, Benedetta; Sordi, Benedetta; Pasquini, Andrea; Imbriani, Corrado; Annunziato, Francesco; Vannucchi, Alessandro Maria; Nozzoli, Chiara
Salarin C inhibits maintenance of hypoxia-selected Chronic Myeloid Leukemia progenitor cells
2015 Del Poggetto, E; Tanturli, M; Ben-Califa, N; Gozzini, A; Tusa, I; Cheloni, G; Marzi, I; Cipolleschi, M G; Kashman, Y; Neumann, D; Rovida, E; Dello Sbarba, P
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| ACETYLATION INDUCED BY BUTYRATES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA CAN LEAD TO DIFFENTIATION | 2002 | A. Gozzini; E. Rovida; A Pratesi; P. Dello Sbarba; P Rossi Ferrini; V. Santini | |
| Acetylome and phosphoproteome modifications in imatinib resistant chronic myeloid leukaemia cells treated with valproic acid. | 2011 | Buchi F; Pastorelli R; Ferrari G; Spinelli E; Gozzini A; Sassolini F; Bosi A; Tombaccini D; Santini V | |
| Autologous haematopoietic stem cell transplantation affects long-term progression independent of relapse activity in aggressive multiple sclerosis: a comparative matched study | 2025 | Mariottini, Alice; Mazzeo, Anna Chiara; Simonetti, Edoardo; Boncompagni, Riccardo; Covicchio, Jessica; Barilaro, Alessandro; Cutini, Ilaria; Di Cristinzi, Maria; Gozzini, Antonella; Mattei, Alessandra; Mealli, Fabrizia; Repice, Anna Maria; Nozzoli, Chiara; Massacesi, Luca | |
| Autologous haematopoietic stem cell transplantation affects paramagnetic rim lesions in multiple sclerosis | 2026 | Mariottini, Alice; Ginestroni, Andrea; Carlesi, Edoardo; Di Pasquale, Francesca; Simonetti, Edoardo; Noferini, Linhsia; Gozzini, Antonella; Costantini, Gaia; Repice, Anna M.; Reich, Daniel S.; Fainardi, Enrico; Nozzoli, Chiara; Massacesi, Luca | |
| Butyrates as single drug induce histone acetylation and granulocytic maturation: possible selectivity on core binding factor-acute myeloid leukemia blasts. | 2003 | A.GOZZINI; E.ROVIDA; P.DELLO SBARBA; S.GALIMBERTI; V. SANTINI | |
| Complete remission with brentuximab vedotin in a case of primary cutaneous gamma-delta T-cell lymphoma relapsed after allogeneic stem cell transplantation | 2021 | Lastrucci, Irene; Grandi, Vieri; Gozzini, Antonella; Vannucchi, Margherita; Kovalchuk, Sofya; Santucci, Marco; Pimpinelli, Nicola | |
| EPIGENETIC MODIFICATIONS IN A T(8;21) ACUTE MYELOID LEUKEMIA CELL LINE CAUSED BY ADMINISTRATION OF THE HDAC INHIBITOR D1 | 2004 | V. Barbetti; E. Rovida; A. Gozzini; S. Giuntoli; V. Santini; P. Dello Sbarba | |
| Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine | 2014 | VALENCIA MARTINEZ, ANA BELEN; Masala, Erico; Rossi, A.; Martino, A.; Sanna, A.; Buchi, Francesca; Canzian, F.; Cilloni, D.; Gaidano, V.; Voso, M. T.; Kosmider, O.; Fontenay, M.; Gozzini, A.; Bosi, Alberto; Santini, Valeria | |
| Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine. | 2014 | Valencia A; Masala E; Rossi A; Martino A; Sanna A; Buchi F; Canzian F; Cilloni D; Gaidano V; Voso MT; Kosmider O; Fontenay M; Gozzini A; Bosi A; Santini V. | |
| Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients. | 2016 | Bocchia, M; Galimberti, S; Aprile, L; Sicuranza, A; Gozzini, A; Santilli, F; Abruzzese, E; Baratè, C; Scappini, B; Fontanelli, G; Trawinska, Mm; Defina, M; Gozzetti, A; Bosi, A; Petrini, M; Puccetti, L | |
| HDAC INHIBITORS IN COMBINATION WITH HYPOMETHYLATING AGENTS INDUCE SPECIFIC CHROMATIN MODIFICATION AND TRANSCRIPTIONAL ACTIVATION IN CBF/AML CELLS | 2005 | A. Gozzini; V. Barbetti; E. Rovida; S. Giuntoli; P. Dello Sbarba; V. Santini | |
| In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features | 2020 | Tusa I.; Cheloni G.; Poteti M.; Silvano A.; Tubita A.; Lombardi Z.; Gozzini A.; Caporale R.; Scappini B.; Dello Sbarba P.; Rovida E. | |
| INCUBATION OF MURINE ERYTHROLEUKEMIA CELLS IN SEVERE HYPOXIA INDUCES MASSIVE APOPTOSIS PARALLELED BY AKT AND ERK5 CLEAVAGE | 2004 | S. Giuntoli; E. Rovida; V. Barbetti; A. Gozzini; P. Dello Sbarba | |
| Iron overload and iron chelation therapy in patients with myelodysplastic syndrome treated by allogeneic stem-cell transplantation: Report from the working conference on iron chelation of the Gruppo Italiano Trapianto di Midollo | 2011 | Alessandrino EP; Angelucci E; Cazzola M; Porta MG; Di Bartolomeo P; Gozzini A; Malcovati L; Pioltelli P; Sica S; Bosi A | |
| Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib | 2015 | Castagnetti, F; Gugliotta, G; Breccia, M; Stagno, F; Iurlo, A; Albano, F; Abruzzese, E; Martino, B; Levato, L; Intermesoli, T; Pregno, P; Rossi, G; Gherlinzoni, F; Leoni, P; Cavazzini, F; Venturi, C; Soverini, S; Testoni, N; Alimena, G; Cavo, M; Martinelli, G; Pane, F; Saglio, G; Rosti, G; Baccarani, M; Bosi, A; Gozzini, A | |
| MAPKS ARE INVOLVED IN THE SURVIVAL AND DIFFERENTIATION OF A T(8;21) ACUTE MYELOID LEUKEMIA CELL LINE AND ARE MODULATED BY THE HDAC INHIBITOR D1 | 2004 | E. Rovida; A. Gozzini; V. Barbetti; S. Giuntoli; V. Santini; P. Dello Sbarba | |
| Mutated ASXL1 and number of somatic mutations as possible indicators of progression to chronic myelomonocytic leukemia of myelodysplastic syndromes with single or multilineage dysplasia | 2017 | Valencia-Martinez, Ana; Sanna, Alessandro; Masala, Erico; Contini, Elisa; Brogi, Alice; Gozzini, Antonella; Santini, Valeria | |
| Redistribution of H3K27me3 and acetylated histone H4 upon exposure to azacitidine and decitabine results in de-repression of the AML1/ETO target gene IL3. | 2014 | Buchi F; Masala E; Rossi A; Valencia A; Spinelli E; Sanna A; Gozzini A; Santini V. | |
| Safety of Prophylactic Anakinra in Patients Treated with CD28-Based CD19 Chimeric Antigen Receptor-T Cells for R/R B-Cell Lymphoma | 2026 | Cutini, Ilaria; Camerini, Chiara; Coltro, Giacomo; Gozzini, Antonella; Simonetti, Edoardo; Giordano, Mirella; Mirabella, Gaia; Mazzoni, Alessio; Matani, Francesca; Caporale, Roberto; Bencini, Sara; Peruzzi, Benedetta; Nassi, Luca; Puccini, Benedetta; Sordi, Benedetta; Pasquini, Andrea; Imbriani, Corrado; Annunziato, Francesco; Vannucchi, Alessandro Maria; Nozzoli, Chiara | |
| Salarin C inhibits maintenance of hypoxia-selected Chronic Myeloid Leukemia progenitor cells | 2015 | Del Poggetto, E; Tanturli, M; Ben-Califa, N; Gozzini, A; Tusa, I; Cheloni, G; Marzi, I; Cipolleschi, M G; Kashman, Y; Neumann, D; Rovida, E; Dello Sbarba, P |